NZ519112A - Drug delivery device for administration of active agent to mammary gland cavity - Google Patents

Drug delivery device for administration of active agent to mammary gland cavity

Info

Publication number
NZ519112A
NZ519112A NZ519112A NZ51911202A NZ519112A NZ 519112 A NZ519112 A NZ 519112A NZ 519112 A NZ519112 A NZ 519112A NZ 51911202 A NZ51911202 A NZ 51911202A NZ 519112 A NZ519112 A NZ 519112A
Authority
NZ
New Zealand
Prior art keywords
active agent
mammary gland
administration
delivery device
drug delivery
Prior art date
Application number
NZ519112A
Other languages
English (en)
Inventor
Craig Robert Bunt
Michael John Rathbone
Colin Roger Ogle
Original Assignee
Interag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interag filed Critical Interag
Priority to NZ519112A priority Critical patent/NZ519112A/xx
Priority to PCT/NZ2003/000099 priority patent/WO2003097109A1/fr
Priority to EP03725921A priority patent/EP1551330A1/fr
Priority to CA002486468A priority patent/CA2486468A1/fr
Priority to JP2004505104A priority patent/JP2005535591A/ja
Priority to AU2003228177A priority patent/AU2003228177A1/en
Priority to US10/994,211 priority patent/US20050152939A1/en
Publication of NZ519112A publication Critical patent/NZ519112A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NZ519112A 2002-05-22 2002-05-22 Drug delivery device for administration of active agent to mammary gland cavity NZ519112A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NZ519112A NZ519112A (en) 2002-05-22 2002-05-22 Drug delivery device for administration of active agent to mammary gland cavity
PCT/NZ2003/000099 WO2003097109A1 (fr) 2002-05-22 2003-05-22 Ameliorations dans la technologie de l'apport
EP03725921A EP1551330A1 (fr) 2002-05-22 2003-05-22 Ameliorations dans la technologie de l'apport
CA002486468A CA2486468A1 (fr) 2002-05-22 2003-05-22 Ameliorations dans la technologie de l'apport
JP2004505104A JP2005535591A (ja) 2002-05-22 2003-05-22 薬物輸送技術の改良
AU2003228177A AU2003228177A1 (en) 2002-05-22 2003-05-22 Improvements in delivery technology
US10/994,211 US20050152939A1 (en) 2002-05-22 2004-11-19 Delivery technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ519112A NZ519112A (en) 2002-05-22 2002-05-22 Drug delivery device for administration of active agent to mammary gland cavity

Publications (1)

Publication Number Publication Date
NZ519112A true NZ519112A (en) 2004-12-24

Family

ID=29546535

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ519112A NZ519112A (en) 2002-05-22 2002-05-22 Drug delivery device for administration of active agent to mammary gland cavity

Country Status (6)

Country Link
EP (1) EP1551330A1 (fr)
JP (1) JP2005535591A (fr)
AU (1) AU2003228177A1 (fr)
CA (1) CA2486468A1 (fr)
NZ (1) NZ519112A (fr)
WO (1) WO2003097109A1 (fr)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1899492A (en) * 1929-10-24 1933-02-28 Ward L Beebe Teat dilator
US2244027A (en) * 1938-10-31 1941-06-03 Benjamin D Smith Teat dilator
US2704076A (en) * 1953-02-20 1955-03-15 Herbert J Larson Dilators
US2832343A (en) * 1955-04-12 1958-04-29 Mose Clara Emilie Marie Dilators
FR2247204A1 (en) * 1973-10-16 1975-05-09 Girardiere Gf Veterinary aerosol foams - contg alginic acid derivs as film-formers for injection into cows teats, vagina or uterus
CA1052697A (fr) * 1974-03-29 1979-04-17 Upjohn Company (The) Compose therapeutique contre la mastite chez les mammiferes
US3938517A (en) * 1975-03-14 1976-02-17 Anderson Carsten D Teat cautery bullet
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
GB8417810D0 (en) * 1984-07-12 1984-08-15 Graham N B Temperature/fluid sensitive devices
US5116619A (en) * 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
NZ258199A (en) * 1992-12-08 1997-01-29 Bimeda Research & Dev Ltd Veterinary composition for treating mastitis comprising an aqueous suspension of an insoluble salt of cloxacillin benzathine
IT1283324B1 (it) * 1996-04-02 1998-04-16 Fatro Spa Composizioni veterinarie a base di antibatterici per uso intramammario
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients

Also Published As

Publication number Publication date
AU2003228177A1 (en) 2003-12-02
WO2003097109A1 (fr) 2003-11-27
CA2486468A1 (fr) 2003-11-27
JP2005535591A (ja) 2005-11-24
EP1551330A4 (fr) 2005-07-13
EP1551330A1 (fr) 2005-07-13

Similar Documents

Publication Publication Date Title
CA2350838A1 (fr) Systeme a liberation controlee pour l'administration d'agents therapeutiques a l'interieur de l'oreille interne
IL195055A0 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
MXPA04001505A (es) Jeringa alargada.
GEP20043315B (en) Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof
GEP20053473B (en) High Potency Dihydroergotamine Compositions
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
IL190838A0 (en) Intranasal administration of rapid acting insulin
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
AU7315301A (en) Compounds and compositions for delivering active agents
GEP20063895B (en) Platinum derivative pharmaceutical formulations
AU2274201A (en) Compounds and compositions for delivering active agents
AU2003228858A1 (en) Energetically-controlled delivery of biologically active material from an implanted medical device
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
YU23402A (sh) Kompozicije sa kontrolisanim oslobađanjem koje sadrže nimezulid
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
IL150818A0 (en) Composition for intestinal delivery
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
NZ519112A (en) Drug delivery device for administration of active agent to mammary gland cavity
PT1246662E (pt) Sistema de administracao de um agente benefico ormotico
SI1558219T1 (sl) Farmacevtska formulacija olanzapina
NZ513981A (en) Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
WO2003101378A3 (fr) Formulation pharmaceutique dans un systeme d'administration de medicaments et son procede de preparation
TW200635616A (en) Organic compounds

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 22 MAY 2016 BY JAMES + WELLS

Effective date: 20130816

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 22 MAY 2023 BY JAMES + WELLS

Effective date: 20140909

EXPY Patent expired